Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism with an H index of 49. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on endocrinology, metabolism, metabolic diseases, diabetes. It has an SJR impact factor of 1,381 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,381.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,381
H-index
49
Docs (year)
39
Docs 3y
144
Total refs
2338
Cites 3y
680
Citable 3y
140
Cites/Doc 2y
4.48
Ref/Doc
59.95
Immediate OA
1800 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
View moreVitamin D and rheumatoid arthritis
View moreDesign of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope® in children requiring growth hormone treatment
View moreDedicated to evidence-based medicine and the evaluation of new therapeutic approaches in the field
View moreDapagliflozin in patients with type 2 diabetes mellitus
View moreCross-sectional correlates of increased IL-18 but reduced fetuin-A and oxytocin with adiposity and blood indices in metabolic syndrome patients with and without prediabetes
View moreCorrelation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia
View moreComparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients
View moreComparison of conventional risk factors in middle-aged versus elderly diabetic and nondiabetic patients with myocardial infarction: prediction with decision-analytic model
View moreComparative evaluation of short-term biomarker response to treatment for growth hormone deficiency in Chinese children with growth hormone deficiency born small for or appropriate for gestational age: a randomized phase IV open-label study
View moreClosing sale of innovative treatment options for the treatment of diabetes and metabolic disorders?
View moreClinically and pharmacologically relevant interactions of antidiabetic drugs
View moreClinical and socio-demographic parameters contributing to treatment incompliance in Palestinian patients with diabetes
View more5-alpha-dihydrotestosterone elevations associated with phentermine use
View moreCan a modified theory of planned behavior explain the effects of empowerment education for people with type 2 diabetes?
View moreBrugada ECG pattern during hyperkalemic diabetic ketoacidosis
View moreBlood versus urine ketone monitoring in a pediatric cohort of patients with type 1 diabetes: a crossover study
View moreBasal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making
View moreBariatric surgery in patients with type 1 diabetes: special considerations are warranted
View moreAwareness of diabetic retinopathy among people with diabetes in Jeddah, Saudi Arabia
View moreAntidiabetic phytoconstituents and their mode of action on metabolic pathways
View moreAntidiabetic medications and mortality reduction: a shift from surrogate to clinical endpoints
View moreAdverse orthopedic effect of exogenous estrogens on men undergoing cross-gender hormonal therapy
View moreA qualitative study of users' experiences after 3months: the first Rwandan diabetes self-management Smartphone application "Kir'App"
View more